Vanderbilt-ingram Cancer Center
Clinical trials sponsored by Vanderbilt-ingram Cancer Center, explained in plain language.
-
New PET tracer aims to sharpen view of HER2 cancers
Diagnosis Not yet recruitingThis early-phase study will test a radioactive tracer called [68Ga]Ga-ABY-025 during PET scans to see if it can better identify HER2-positive tumors in people with advanced or metastatic cancer. About 30 adults who are already receiving standard HER2-targeted therapy will receive…
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated May 01, 2026 16:00 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
Diagnosis Not yet recruitingThis early-stage study tests whether a fluorescent dye attached to the cancer drug nivolumab can safely help surgeons see head and neck tumors during surgery. About 40 adults with head and neck cancer will receive the dye before their standard surgery. The goal is to check for si…
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated May 01, 2026 15:57 UTC